Structural Modification of the 3,4,5-Trimethoxyphenyl Moiety in the Tubulin Inhibitor VERU-111 Leads to Improved Antiproliferative Activities.
Wang, Q., Arnst, K.E., Wang, Y., Kumar, G., Ma, D., Chen, H., Wu, Z., Yang, J., White, S.W., Miller, D.D., Li, W.(2018) J Med Chem 61: 7877-7891
- PubMed: 30122035 
- DOI: 10.1021/acs.jmedchem.8b00827
- Primary Citation of Related Structures:  
6D88 - PubMed Abstract: 
Colchicine binding site inhibitors (CBSIs) hold great potential in developing new generations of antimitotic drugs. Unlike existing tubulin inhibitors such as paclitaxel, they are generally much less susceptible to resistance caused by the overexpression ...